Skip to main navigation Skip to search Skip to main content

An open label safety and eficacy study of Cifdinir oral suspension, once daily in pediatric subjects with acute ottis media

Project: Research

Project Details

StatusFinished
Effective start/end date10/1/02 → 09/30/03

Funding

  • Abbott Laboratories: $18,119.00